Global Multiplex Assay Market

Multiplex Assay Market Size, Share, Growth Analysis, By Product(Consumables, Instruments and Software), By Type(Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology(Flow Cytometry, Fluorescence Detection), By Application(Research & Development, and Clinical Diagnostics) - Industry Forecast 2024-2031


Report ID: SQMIG35H2180 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 117 | Figures: 77

Multiplex Assay Market Regional Insights

Asia-Pacific is projected to expand greatly between 2023 and 2030 as a result of increased government initiatives to increase awareness, an increase in medical tourism, expanding research activities in the region, a supportive regulatory environment that will increase the adoption rate for microbiology testing and other advanced diagnostic methods, as well as the region's growing demand for high-quality healthcare.

North America dominated the global industry in 2022 and accounted for the largest share of more than 36.88% of the total revenue because of the rising R&D activities for the discovery of novel medications and diagnosis & treatment options. The region's expansion is anticipated to be fueled by the rise in government funding for the discovery of new biomarkers and the rise in the prevalence of chronic illnesses like cancer and stroke. Additionally, the presence of significant players in the region is likely to boost the rise. On the other hand, Asia Pacific is anticipated to grow at the fastest pace during the anticipated years. This is owing to the improving healthcare infrastructure and medical research scenario in emerging nations.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Multiplex Assay Market size was valued at around USD 2.05 billion in 2022 and is expected to rise from USD 2.35 billion in 2023 to reach a value of USD 7.08 Billion by 2031, at a CAGR of 14.77% over the forecast period (2024–2031).

To increase their market presence, leading corporations are putting a variety of methods into practice, including partnerships, the introduction of cutting-edge technology & goods, and collaborations. For instance, Bio-Rad and Seegene announced their collaboration in June 2021 in order to offer molecular diagnostic testing solutions in the American market. Additionally, Qiagen introduced the NeuMoDx multiplex assay in November 2020 to offer a comprehensive selection of testing options for SARS-CoV-2 in Europe and international markets. 'Thermo Fisher Scientific Inc.', 'Bio-Rad Laboratories, Inc.', 'Illumina, Inc.', 'Agilent Technologies, Inc.', 'Luminex Corporation', 'Merck KGaA', 'QIAGEN N.V.', 'Roche Diagnostics', 'Randox Laboratories Ltd.', 'Bio-Techne Corporation', 'Abcam plc', 'GenScript Biotech Corporation', 'Mesoscale Discovery, LLC', 'Seegene Inc.', 'Becton, Dickinson and Company', 'Fluidigm Corporation', 'Meso Scale Diagnostics, LLC', 'PerkinElmer, Inc.', 'Siemens Healthineers AG', 'Biocartis NV'

The growing demand for personalized medicine is driving the demand for multiplex assays. These assays enable the simultaneous measurement of multiple biomarkers, allowing for better patient stratification and personalized treatment options.

Increasing adoption of multiplex immunoassays: The demand for multiplex immunoassays is increasing due to their ability to measure multiple proteins in a single sample. These assays are widely used in drug discovery, diagnostic testing, and biomarker identification.

Asia-Pacific is projected to expand greatly between 2023 and 2030 as a result of increased government initiatives to increase awareness, an increase in medical tourism, expanding research activities in the region, a supportive regulatory environment that will increase the adoption rate for microbiology testing and other advanced diagnostic methods, as well as the region's growing demand for high-quality healthcare.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Multiplex Assay Market

Product ID: SQMIG35H2180

$5,300
BUY NOW GET FREE SAMPLE